FMR LLC 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-05 2:03 pm Purchase | 2025-11-28 | 13G | INOVIO PHARMACEUTICALS INC INO | FMR LLC | 9,846,664 14.800% | 9,846,664 (New Position) | Filing |